HTN and CHF
HTN and CHF
HTN and CHF
FAILURE
Hypertension
• Hypertension is defined as an increase in arterial blood
pressure at several determinations that is associated
with increased cardiovascular morbidity and mortality
• no rigidly defined threshold reliably predicts who will
suffer ill effects.
• Nevertheless, sustained diastolic pressures greater
than 90 mmHg, or sustained systolic pressures in
excess of 140 mm Hg, are associated with an increased
risk of atherosclerosis and are therefore used as cutoffs
in diagnosing hypertension in clinical practice.
• Hypertension is a major health problem in the both developed
and developing world.
• Although it occasionally manifests in an acute aggressive form,
high blood pressure is much more often asymptomatic for many
years.
• Generally, hypertension increases the risk of
stroke
atherosclerotic coronary heart disease,
cardiac hypertrophy and heart failure (hypertensive heart disease)
aortic dissection
multi-infarct dementia
renal failure
• Hypertensive Emergency is when there is
acute impairment of an organ system (CNS,
CVS, Renal). In these conditions, the blood
pressure should be lowered aggressively over
minutes to hours.
• Hypertensive Urgency in which BP is high and
there is potential risk but has not yet caused
acute end-organ damage.
– These patients require BP control over days.
Epidemiology of Hypertension
• The prevalence of pathologic effects of high blood pressure
increases with age and is also higher in African Americans.
• A small percentage of hypertensive patients (approximately
5%) present with a rapidly rising blood pressure that, if
untreated, leads to death within 1 to 2 years
• Such malignant hypertension usually is severe (i.e., systolic
pressures over 200 mm Hg or diastolic pressures over 120
mmHg)
PATHOGENESIS
• Most cases (95%) are idiopathic (essential hypertension).
This form is compatible with long life unless a myocardial
infarction, stroke, or another complication supervenes.
• secondary hypertension are due to primary renal disease,
renal artery narrowing (renovascular hypertension), or
adrenal disorders
• Several relatively rare single-gene disorders cause
hypertension (and hypotension) by affecting renal sodium
resorption
• Although the specific triggers are unknown, it
appears that both altered renal sodium
handling and increased vascular resistance
contribute to essential hypertension.
MORPHOLOGY
• Hypertension not only accelerates atherogenesis
but also causes degenerative changes in the
walls of large and medium sized arteries that
can lead to aortic dissection and cerebrovascular
hemorrhage.
• Two forms of small blood vessel disease are
hypertension-related: hyaline arteriolosclerosis
and hyperplastic arteriolosclerosis
Diagnostic workup
• Laboratory investigations: Unless a secondary cause for hypertension is
suspected, only the following routine laboratory studies should be performed:
– CBC
– Urinalysis including microscopy , protein , blood and , glucose
– Fasting blood glucose
– Serum electrolytes :
– Lipid profile (total cholesterol, low-density lipoprotein [LDL] and high-density
lipoprotein [HDL], and triglycerides).
– Serum creatinine, uric acid,
ECG
• Imaging Studies:
– Echocardiography: to detect LVH
– CXR (if necessary)
Therapy of Hypertension
• non pharmacologic therapy
– Sodium (salt)restriction
– Lifestyle modifications
• Pharmacologic therapy – involves the use of one or more
of the following agents
– Diuretics
– β-adrenergic blocking agents
– Centrally acting agents
– Vasodilators
– ACE inhibitors
– Angiotensin receptor blockers
HEART FAILURE
HEART FAILURE
• Heart failure generally is referred to as
congestive heart failure (CHF).
• CHF is the common end point for many forms
of cardiac disease and typically is a progressive
condition that carries an extremely poor
prognosis
• Most cases of heart failure are due to systolic
dysfunction—inadequate myocardial
contractile function, characteristically a
consequence of ischemic heart disease or
• Alternatively, CHF also can result from
diastolic dysfunction—inability of the heart to
adequately relax and fill, such as in massive
left ventricular hypertrophy, myocardial
fibrosis, amyloid deposition, or constrictive
pericarditis.
• Finally, heart failure also can be caused by
valve dysfunction (e.g., due to endocarditis) or
can occur in normal hearts suddenly burdened
with an abnormal load (e.g., with fluid or
• CHF occurs when the heart cannot generate
sufficient output to meet the metabolic
demands of the tissues—or can only do so at
higher-than-normal filling pressures;
• In a minority of cases, heart failure can be a
consequence of greatly increased tissue
demands, as in hyperthyroidism,or poor
oxygen carrying capacity as in anemia (high-
output failure).
• CHF onset can be abrupt, as in the setting of a
large myocardial infarct or acute valve
dysfunction.
• In many cases, however, CHF develops
gradually and insidiously owing to the
cumulative effects of chronic work overload or
progressive loss of myocardium.
• Inadequate cardiac output—called forward
failure—is almost always accompanied by
increased congestion of the venous circulation
• The cardiovascular system attempts to
compensate for reduced myocardial
contractility or increased hemodynamic
burden through several homeostatic
mechanisms: